 1 Agents affecting nervous system and sensory organs
|
11 Agents affecting central nervous system
|
 111 General anesthetics
|
112 Hypnotics and sedatives, anxiolytics
|
113 Antiepileptics
|
1131 Phenacemides
|
1132 Hydantoins
|
1133 Oxazolidines
|
1134 Barbiturates
|
1135 Primidones
|
 1136 Aminobutyrates
|
1137 Sulfonamides
|
1139 Others
|
D04148 Fenfluramine hydrochloride (JAN/USAN)
D00332 Gabapentin (JAN/USP/INN)
D00701 Phenobarbital sodium (JAN/USP/INN)
D07583 Phenytoin and phenobarbital
D00539 Ethosuximide (JP18/USP/INN)
D00280 Clonazepam (JP18/USP/INN)
D00252 Carbamazepine (JP18/USP/INN)
D05775 Rufinamide (JAN/USP/INN)
D00710 Valproate sodium (USAN); Sodium valproate (JP18)
D00535 Vigabatrin (JAN/USP/INN)
D00354 Lamotrigine (JAN/USP/INN)
D00537 Topiramate (JAN/USP/INN)
D00709 Levetiracetam (JAN/USP/INN)
D00538 Zonisamide (JP18/USP/INN)
D05928 Stiripentol (JAN/USAN/INN)
D07299 Lacosamide (JAN/USAN/INN)
D10780 Perampanel hydrate (JAN)
D00293 Diazepam (JP18/USP/INN)
D00365 Lorazepam (JP18/USP/INN)
D01253 Clobazam (JAN/USAN/INN)
D00531 Nitrazepam (JP18/USAN/INN)
D00550 Midazolam (JAN/USP/INN)
D01731 Potassium bromide (JP18/USP)
D02055 Sodium bromide (JP18)
|
114 Antipyretics and analgesics, anti-inflammatory agents
|
115 Stimulants
|
116 Antiparkinsonian agents
|
117 Psychotropics
|
118 Common cold drugs
|
119 Miscellaneous
|
12 Agents affecting peripheral nervous system
|
13 Agents affecting sensory organs
|
19 Other agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan